Tianjin Tianyao Pharmaceuticals Co Ltd - ESG Rating & Company Profile powered by AI
The Sustainability score for Tianjin Tianyao Pharmaceuticals Co Ltd represents its reporting of the UN SDGs. This page displays a free ESG analysis for Tianjin Tianyao Pharmaceuticals Co Ltd. Complete ESG analysis of Tianjin Tianyao Pharmaceuticals Co Ltd can be reached by logging in.
Tianjin Tianyao Pharmaceuticals Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Tianjin Tianyao Pharmaceuticals Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Tianjin Tianyao Pharmaceuticals Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose current and historical energy intensity?
Does Tianjin Tianyao Pharmaceuticals Co Ltd report the average age of the workforce?
Does Tianjin Tianyao Pharmaceuticals Co Ltd reference operational or capital allocation in relation to climate change?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose its ethnicity pay gap?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose cybersecurity risks?
Does Tianjin Tianyao Pharmaceuticals Co Ltd offer flexible work?
Does Tianjin Tianyao Pharmaceuticals Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose the number of employees in R&D functions?
Does Tianjin Tianyao Pharmaceuticals Co Ltd conduct supply chain audits?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Tianjin Tianyao Pharmaceuticals Co Ltd conduct 360 degree staff reviews?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose the individual responsible for D&I?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose current and / or historical scope 2 emissions?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose water use targets?
Does Tianjin Tianyao Pharmaceuticals Co Ltd have careers partnerships with academic institutions?
Did Tianjin Tianyao Pharmaceuticals Co Ltd have a product recall in the last two years?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose incidents of discrimination?
Does Tianjin Tianyao Pharmaceuticals Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Tianjin Tianyao Pharmaceuticals Co Ltd issued a profit warning in the past 24 months?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose parental leave metrics?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose climate scenario or pathway analysis?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose the pay ratio of women to men?
Does Tianjin Tianyao Pharmaceuticals Co Ltd support suppliers with sustainability related research and development?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Tianjin Tianyao Pharmaceuticals Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Tianjin Tianyao Pharmaceuticals Co Ltd involved in embryonic stem cell research?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose GHG and Air Emissions intensity?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose its waste policy?
Does Tianjin Tianyao Pharmaceuticals Co Ltd report according to TCFD requirements?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose energy use targets?
Does Tianjin Tianyao Pharmaceuticals Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Tianjin Tianyao Pharmaceuticals Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Tianjin Tianyao Pharmaceuticals Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research, manufacture, and export of pharmaceutical APIs in Asia. It primarily provides corticosteroid, cardio cerebrovascular, and analgesic APIs and formulations. The company offers bulk drugs, including dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, triamcinlone acetonide acetate, prednisone acetate, prednisone, prednisolone, flucinonide, halcinonide, triamcinolone acetonide, clobetasol propionate, betamethasone, methylprednisolone hydrocortisone acetate, methylprednisolone, and triamcinolone. The company is based in Tianjin, China. Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHSE : 600488) operates as a subsidiary of Jinhushen Biomedical Technology Co., Ltd.